| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 08/30/2001 | WO2001062297A1 Compositions and methods for enhancing drug delivery across biological membranes and tissues |
| 08/30/2001 | WO2001062156A1 Novel indocyanine dyes |
| 08/30/2001 | WO2001014408A3 Method for coupling, in solution, a peptide with at least another compound and uses thereof |
| 08/30/2001 | WO2000040597A9 Method and composition for angiogenesis inhibition |
| 08/30/2001 | US20010018511 Anticancer agent |
| 08/30/2001 | US20010018422 Anticancer agents |
| 08/30/2001 | CA2400215A1 Hla binding peptides and their uses |
| 08/30/2001 | CA2400099A1 Compositions and methods for enhancing drug delivery across biological membranes and tissues |
| 08/29/2001 | EP1127869A1 Novel compounds and medicinal use thereof |
| 08/29/2001 | EP1127119A1 Compounds and methods for modulating claudin-mediated functions |
| 08/29/2001 | EP1127068A1 Immunotherapeutic methods using epitopes of wt-1 and gata-1 |
| 08/29/2001 | CN1310763A New peptide fragments for protein purification |
| 08/29/2001 | CN1310724A Novel peptides for use in immunotherapy of autoimmune diseases |
| 08/29/2001 | CN1310626A Hybrid polypeptides with enhanced pharmacokinetic properties |
| 08/29/2001 | CN1070198C Isolated nucleic acid molecule of coded tumor rejection antigen precursor DAGE and its application |
| 08/28/2001 | US6281376 Therapeutic compound—fatty acid conjugates |
| 08/28/2001 | US6280974 Nucleotide sequence coding viral protein; for use as diagnostic tool in detection of viral diseases |
| 08/28/2001 | CA2096112C Hexapeptides deriving from aglucoteicoplanin and a process for preparing them |
| 08/28/2001 | CA2054706C Very large scale immobilized polymer synthesis |
| 08/28/2001 | CA2052455C Teicoplanin recovery process |
| 08/28/2001 | CA1341287C Polypeptides derived from human papillomavirus, antibodies to said polypeptide and detection of human papillomavirus latent proteins |
| 08/25/2001 | CA2337923A1 Peptide antibiotics |
| 08/23/2001 | WO2001061346A2 Methods for identifying agents causing a lethal phenotype |
| 08/23/2001 | WO2001061017A2 Modified cytokines for use in cancer therapy |
| 08/23/2001 | WO2001060852A1 A 52 kDa PROTEIN FROM COAGULASE NEGATIVE STAPHYLOCOCCI AND FRAGMENTS THEREOF |
| 08/23/2001 | WO2001060846A1 Cyclic hexapeptide derivatives |
| 08/23/2001 | WO2001060845A1 Novel echinocandin derivatives, preparation method and use thereof as fungicides |
| 08/23/2001 | WO2001060844A2 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system |
| 08/23/2001 | WO2001060391A1 A universal vaccine and method for treating cancer employing telomerase reverse transcriptase |
| 08/23/2001 | WO2001060162A2 Cationic, amphipathic beta-sheet peptides and uses thereof |
| 08/23/2001 | WO2001010892A3 Peptide antagonists of factor VIIA |
| 08/23/2001 | US20010016643 Peptide derivatives |
| 08/23/2001 | CA2400588A1 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system |
| 08/23/2001 | CA2400328A1 Methods for identifying agents that cause a lethal phenotype, and agents thereof |
| 08/23/2001 | CA2399816A1 A universal vaccine and method for treating cancer employing telomerase reverse transcriptase |
| 08/23/2001 | CA2399668A1 Cationic, amphipathic beta-sheet peptides and uses thereof |
| 08/22/2001 | EP1124847A1 Lhrh analogues for the treatment of osteoporosis |
| 08/22/2001 | EP1124574A2 Component for vaccine against serogroup b meningococci |
| 08/22/2001 | CN1309661A Labelled glutamine and lysine analogues |
| 08/21/2001 | US6278038 Mammalian melanocortin receptors and uses |
| 08/21/2001 | US6277958 Using fluoren-9-ylmethoxycarbonyl amino acids and a solid phase to form dipeptide; process does not use methylene chloride |
| 08/21/2001 | US6277956 Isolated peptide of defined amino acid sequence which binds to a hla-a2 (human leukocyte antigen-a2) and provokes proliferation of cytolytic t cells; immunology; oncology; vaccines |
| 08/21/2001 | US6277824 Enhancing or inhibiting cadherin-mediated functions comprising a his-ala-val sequence binding motif, an peptidomimetic or an antibody that binds to such a motif |
| 08/21/2001 | US6277583 Affinity labeling libraries and applications thereof |
| 08/21/2001 | US6277356 Somatostatin peptides, use as a radiopharmaceutical, e.g. for radiotherapy of somatostatin receptor tumors, complexed with y90 |
| 08/21/2001 | CA2097916C Subunit papillomavirus vaccine and peptides for use therein |
| 08/16/2001 | WO2001058934A2 Kahalalide f and related compounds |
| 08/16/2001 | WO2001058930A1 Par4 peptides and polypeptides |
| 08/16/2001 | WO2001058929A1 Azapeptides useful in the treatment of hepatitis c |
| 08/16/2001 | WO2001058471A2 Novel amino acid and peptide inhibitors of staphylococcus virulence |
| 08/16/2001 | WO2001010893A3 Il-16 antagonists |
| 08/16/2001 | WO2001010891A3 Il-16 antagonists |
| 08/16/2001 | WO2001009173A3 Use of quinic, shikimic acids and their derivatives for preparing mannose receptor ligands |
| 08/16/2001 | WO2000036093A9 Intein-mediated cyclization of peptides |
| 08/16/2001 | US20010014456 Binding molecules for human factor VIII and factor VIII-like proteins |
| 08/16/2001 | EP1123387A2 Mn gene and protein |
| 08/16/2001 | EP1123112A1 Ionic molecular conjugates of n-acylated derivatives of poly (2-amino-2-deoxy-d-glucose) and polypeptides |
| 08/16/2001 | EP1123109A1 Contulakin-g, analogs thereof and uses therefor |
| 08/16/2001 | EP0710247B1 Process for manufacture of 1-deamino-8-d-arginine vasopressin |
| 08/16/2001 | EP0670729B1 Use of insulin-like growth factors and analogs for TREATING RETINAL NEURONAL DISORDERS |
| 08/16/2001 | CA2399566A1 Par4 peptides and polypeptides |
| 08/15/2001 | CN1308635A Novel cyclosporin with improved activity profile |
| 08/15/2001 | CN1308086A Antibiotic/antiendotoxic mimic peptide and its preparation and application |
| 08/14/2001 | US6274702 Bone stimulating factor |
| 08/14/2001 | US6274613 Cyclic imines as pesticides |
| 08/14/2001 | US6274551 Cytotoxic and antiviral compound |
| 08/14/2001 | US6274134 Human cell adhesion protein AAMP-1 and uses thereof |
| 08/14/2001 | US6273598 Computer system and methods for producing morphogen analogs of human OP-1 |
| 08/14/2001 | CA2037959C Cyclohexapeptides compound |
| 08/14/2001 | CA1341285C Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines |
| 08/09/2001 | WO2001057074A1 Ligands for fpr class receptors that induce a host immune response to a pathogen or inhibit hiv infection |
| 08/09/2001 | WO2001057072A2 Pharmacologically active antiviral peptides and methods of their use |
| 08/09/2001 | WO2001057070A1 Melanin-concentrating hormone analogs |
| 08/09/2001 | WO2001057069A2 Targeting peptides |
| 08/09/2001 | WO2001057067A1 Ligand for vascular endothelial growth factor receptor |
| 08/09/2001 | WO2001056591A1 vMIP-II PEPTIDE ANTAGONISTS OF CXCR4 |
| 08/09/2001 | DE10004667A1 Neues ß-Defensin, hBD-3, Herstellung und seine Anwendung New beta-defensin hBD-3, Processing and its Application |
| 08/09/2001 | CA2399509A1 Melanin-concentrating hormone analogs |
| 08/09/2001 | CA2399058A1 Targeting peptides |
| 08/09/2001 | CA2399032A1 Ligands for fpr class receptors that induce a host immune response to a pathogen or inhibit hiv infection |
| 08/09/2001 | CA2399022A1 Ligand for vascular endothelial growth factor receptor |
| 08/09/2001 | CA2369056A1 Vmip-ii peptide antagonists of cxcr4 |
| 08/08/2001 | EP1121431A1 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 08/08/2001 | EP1121383A1 Methods for the production of antibodies to specific regions of cyclosporine and cyclosporine metabolites |
| 08/08/2001 | EP1121381A2 Zinc finger binding domains for gnn |
| 08/08/2001 | EP1121378A1 A process for the preparation of a thrombus imaging agent |
| 08/08/2001 | CN1307481A Methods for treating hot flashes and gynaecomastia |
| 08/08/2001 | CN1306965A Bacteriocidal/permeation enhanced protein functional area bioactive pipetide |
| 08/07/2001 | US6271344 Enhanced affinity hyaluronan binding peptides |
| 08/07/2001 | US6271202 Administering neuropeptide |
| 08/07/2001 | US6271196 Polypeptide |
| 08/07/2001 | US6270957 Non-Imuunosuppressive cyclosporins and their use in the prevention and treatment of HIV infection |
| 08/07/2001 | CA2044746C Polypeptide compound and a process for preparation thereof |
| 08/02/2001 | WO2001055725A2 Diagnosis of tauopathies determining tau/phospho-tau ratio |
| 08/02/2001 | WO2001055215A1 Therapeutic peptides |
| 08/02/2001 | WO2001055177A2 Methods to identify ctl epitopes of hiv |
| 08/02/2001 | WO2001055176A2 Methods for inhibiting smooth muscle cell proliferation |
| 08/02/2001 | WO2001018059A3 Congener independent detection of microcystin and nodularin congeners |
| 08/02/2001 | WO2000066175A3 Conjugates as therapies for cancer and prostate diseases |
| 08/02/2001 | US20010011072 Skin disorders; kidney and liver disorders |